Stable Supply

STABLE SUPPLY

From conception to development to commercialisation, our growth is aided by cost-effective drug development and substantial manufacturing. Bright Future provides a stable supply of high-quality and reliable products. With four main manufacturing sites located in Hong Kong, Haikou, Los Angeles and Hamburg, Bright Future has manufacturing capabilities for stable production of both drugs and health products across our value chain. We market and distribute our products in over 12 countries. We are also engaged in contract manufacturing with state-of-the-art equipment, whereby we undertake selected contracts with pharmaceutical companies to manufacture and supply pharmaceutical and healthcare products.
State-of-the-art manufacturing capabilities

Hong Kong

Haikou

Los Angeles

Hamburg

Accreditations
We have four state-of-the-art formulation manufacturing facilities located in Hong Kong, Haikou, Los Angeles and Hamburg. Our facilities have received accreditations from the following regulatory bodies:
PIC/S
FDA
GMP
EU GMP
cGMP
HALAL
HACCP
NSF
ISO 45001
ISO 22000: 2005
HKQAA-HACCP
Business model
Service
  • Commercial manufacturing
  • Solid, semi-solid and liquid dosage forms
  • Immediate and extended release
  • Core-tablets, sugar-coated tablets, film-coated tablets
  • Capsules, Pellets, multi-component capsules, liquid-filled capsules, vegetarian capsules
  • Granules, powder, Pills
Core strengths
  • Vertically integrated operations from conception to commercialization
  • Large manufacturing capabilities for a diversified product portfolio
  • Efficient regulatory affairs team ensuring market compliance
  • Dedicated R&D setup for finished dosages
  • Technology and expertise for specialty formulations
Facilities Overview for Download
Usage of cookies
Bright Future uses cookies on its websites to improve user experience. If you click 'OK', you consent to the use of cookies.
OK